European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias
Authors:
- Philippe CoumelPCPhilippe Coumel
- Jean-François LeclercqJLJean-François Leclercq
- Patrick AssayagPAPatrick Assayag
- 1 January 1984
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 54 (9) , 60D-66D
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexesThe American Journal of Cardiology, 1984
- Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaThe American Journal of Cardiology, 1983
- Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.Circulation, 1982
- Role of sympathetic nervous system in non-ischaemic ventricular arrhythmias.Heart, 1982
- Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1981
- Torsades de Pointes: Occurrence in myocardial ischaemia as a separate entity. Multiform ventricular tachycardia or not?European Heart Journal, 1980
- Plasmaspiegel-Wirkungs-Beziehung und Organverteilung von Propafenon*DMW - Deutsche Medizinische Wochenschrift, 1979